|
TIPRL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.359800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.112200E-01 |
| Normal-vs-Stage2 |
4.254400E-01 |
| Normal-vs-Stage3 |
7.930400E-01 |
| Normal-vs-Stage4 |
7.511800E-01 |
| Stage1-vs-Stage2 |
5.272600E-01 |
| Stage1-vs-Stage3 |
5.769600E-01 |
| Stage1-vs-Stage4 |
5.397200E-01 |
| Stage2-vs-Stage3 |
3.514800E-01 |
| Stage2-vs-Stage4 |
3.388800E-01 |
| Stage3-vs-Stage4 |
9.908000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.100800E-01 |
| Normal-vs-AfricanAmerican |
6.559300E-03 |
| Normal-vs-Asian |
9.438000E-01 |
| Caucasian-vs-AfricanAmerican |
7.351600E-04 |
| Caucasian-vs-Asian |
9.125200E-01 |
| AfricanAmerican-vs-Asian |
2.201800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.717600E-01 |
| Normal-vs-Female |
2.294600E-01 |
| Male-vs-Female |
8.509700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.646600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.342000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.543800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.841800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.126600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.072400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.675200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.724000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.372000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.158600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.827800E-01 |
| Normal-vs-Grade 2 |
2.747800E-01 |
| Normal-vs-Grade 3 |
6.710000E-01 |
| Normal-vs-Grade 4 |
5.968000E-01 |
| Grade 1-vs-Grade 2 |
8.261600E-01 |
| Grade 1-vs-Grade 3 |
6.323600E-01 |
| Grade 1-vs-Grade 4 |
5.770400E-01 |
| Grade 2-vs-Grade 3 |
1.148050E-01 |
| Grade 2-vs-Grade 4 |
1.575180E-01 |
| Grade 3-vs-Grade 4 |
8.239000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.851840E-02 |
| Normal-vs-ccB subtype |
4.826400E-01 |
| ccA subtype-vs-ccB subtype |
4.564500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.049800E-01 |
| Normal-vs-N1 |
3.963800E-01 |
| N0-vs-N1 |
6.404600E-01 |
|
|
